berkeley pharma ltd

3.5

berkeley pharma ltd Company Information

Share BERKELEY PHARMA LTD
Dissolved 

Company Number

08537849

Registered Address

2nd floor grove house, 55 lowlands road, harrow, HA1 3AW

Industry

Other human health activities

 

Telephone

-

Next Accounts Due

June 2024

Group Structure

View All

Directors

Milan Patel11 Years

Prashant Patel11 Years

Shareholders

prashant ashwin kumar patel 50%

milan ashwin kumar patel 50%

berkeley pharma ltd Estimated Valuation

£1.7m

Pomanda estimates the enterprise value of BERKELEY PHARMA LTD at £1.7m based on a Turnover of £4m and 0.42x industry multiple (adjusted for size and gross margin).

berkeley pharma ltd Estimated Valuation

£0

Pomanda estimates the enterprise value of BERKELEY PHARMA LTD at £0 based on an EBITDA of £-344.7k and a 3.88x industry multiple (adjusted for size and gross margin).

berkeley pharma ltd Estimated Valuation

£0

Pomanda estimates the enterprise value of BERKELEY PHARMA LTD at £0 based on Net Assets of £-245.7k and 2.32x industry multiple (adjusted for liquidity).

Edit your figures and get a professional valuation report.

Berkeley Pharma Ltd Overview

Berkeley Pharma Ltd is a dissolved company that was located in harrow, HA1 3AW with a Companies House number of 08537849. It operated in the other human health activities sector, SIC Code 86900. Founded in May 2013, it's largest shareholder was prashant ashwin kumar patel with a 50% stake. The last turnover for Berkeley Pharma Ltd was estimated at £4m.

View Sample
View Sample
View Sample

Upgrade for unlimited company reports & a free credit check

Berkeley Pharma Ltd Health Check

Pomanda's financial health check has awarded Berkeley Pharma Ltd a 3.5 rating. We use a traffic light system to show it exceeds the industry average on 4 measures and has 5 areas for improvement. Company Health Check FAQs

Health Check Image
Health Rating3.5out of 5
positive_score

4 Strong

positive_score

2 Regular

positive_score

5 Weak

size

Size

annual sales of £4m, make it larger than the average company (£678.4k)

£4m - Berkeley Pharma Ltd

£678.4k - Industry AVG

growth

Growth

3 year (CAGR) sales growth of 82%, show it is growing at a faster rate (4.4%)

82% - Berkeley Pharma Ltd

4.4% - Industry AVG

production

Production

with a gross margin of 35.1%, this company has a comparable cost of product (35.1%)

35.1% - Berkeley Pharma Ltd

35.1% - Industry AVG

profitability

Profitability

an operating margin of -8.7% make it less profitable than the average company (6.6%)

-8.7% - Berkeley Pharma Ltd

6.6% - Industry AVG

employees

Employees

with 12 employees, this is below the industry average (19)

12 - Berkeley Pharma Ltd

19 - Industry AVG

paystructure

Pay Structure

on an average salary of £22.3k, the company has an equivalent pay structure (£22.3k)

£22.3k - Berkeley Pharma Ltd

£22.3k - Industry AVG

efficiency

Efficiency

resulting in sales per employee of £330.9k, this is more efficient (£39.8k)

£330.9k - Berkeley Pharma Ltd

£39.8k - Industry AVG

debtordays

Debtor Days

There is insufficient data available for this Key Performance Indicator!

- - Berkeley Pharma Ltd

- - Industry AVG

creditordays

Creditor Days

its suppliers are paid after 120 days, this is slower than average (17 days)

120 days - Berkeley Pharma Ltd

17 days - Industry AVG

stockdays

Stock Days

it holds stock equivalent to 61 days, this is more than average (14 days)

61 days - Berkeley Pharma Ltd

14 days - Industry AVG

cashbalance

Cash Balance

has cash to cover current liabilities for 8 weeks, this is less cash available to meet short term requirements (128 weeks)

8 weeks - Berkeley Pharma Ltd

128 weeks - Industry AVG

debtlevel

Debt Level

it has a ratio of liabilities to total assets of 127.2%, this is a higher level of debt than the average (21.3%)

127.2% - Berkeley Pharma Ltd

21.3% - Industry AVG

BERKELEY PHARMA LTD financials

EXPORTms excel logo

Berkeley Pharma Ltd's latest turnover from March 2020 is estimated at £4 million and the company has net assets of -£245.7 thousand. According to their latest financial statements, Berkeley Pharma Ltd has 12 employees and maintains cash reserves of £182.3 thousand as reported in the balance sheet.

Data source: Companies HousePomanda Estimates

Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015May 2014
Turnover3,971,1692,203,4431,647,726659,7631,203,7415,880,5615,137,190
Other Income Or Grants0000000
Cost Of Sales2,575,7271,450,3991,057,093409,305750,6503,663,1983,194,579
Gross Profit1,395,442753,044590,632250,458453,0912,217,3631,942,611
Admin Expenses1,741,043733,593557,771245,931435,2802,195,8571,917,331
Operating Profit-345,60119,45132,8614,52717,81121,50625,280
Interest Payable2110000
Interest Receivable1771,30555599272460274
Pre-Tax Profit-345,42620,75433,4154,62618,08321,96625,554
Tax0-3,943-6,349-925-3,616-4,613-5,366
Profit After Tax-345,42616,81127,0663,70114,46617,35320,188
Dividends Paid0000000
Retained Profit-345,42616,81127,0663,70114,46617,35320,188
Employee Costs267,474174,89384,81983,719696,8283,400,8002,856,120
Number Of Employees1284433156133
EBITDA*-344,71619,87733,8075,70019,27323,33825,280

* Earnings Before Interest, Tax, Depreciation and Amortisation

Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015May 2014
Tangible Assets8,2182,4132,8393,7854,4405,4940
Intangible Assets0000000
Investments & Other0000000
Debtors (Due After 1 year)0000000
Total Fixed Assets8,2182,4132,8393,7854,4405,4940
Stock & work in progress435,150220,001162,66120,50023,35813,91510,227
Trade Debtors0191,595149,05455,2575,956371,282306,408
Group Debtors0000000
Misc Debtors275,86035,22734,516146,684276,53900
Cash182,270170,780177,17044,84534,43374,225109,792
misc current assets1,415000000
total current assets894,695617,603523,401267,286340,286459,422426,427
total assets902,913620,016526,240271,071344,726464,916426,427
Bank overdraft590360000
Bank loan0000000
Trade Creditors 852,356346,741301,608141,055266,030427,275406,139
Group/Directors Accounts0161,365127,36568,374000
other short term finances0000000
hp & lease commitments0000000
other current liabilities296,23912,22514,3575,83426,58900
total current liabilities1,148,654520,331443,366215,263292,619427,275406,139
loans0000000
hp & lease commitments0000000
Accruals and Deferred Income0000000
other liabilities0000000
provisions0000000
total long term liabilities0000000
total liabilities1,148,654520,331443,366215,263292,619427,275406,139
net assets-245,74199,68582,87455,80852,10737,64120,288
total shareholders funds-245,74199,68582,87455,80852,10737,64120,288
Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015May 2014
Operating Activities
Operating Profit-345,60119,45132,8614,52717,81121,50625,280
Depreciation8854269461,1731,4621,8320
Amortisation0000000
Tax0-3,943-6,349-925-3,616-4,613-5,366
Stock215,14957,340142,161-2,8589,4433,68810,227
Debtors49,03843,252-18,371-80,554-88,78764,874306,408
Creditors505,61545,133160,553-124,975-161,24521,136406,139
Accruals and Deferred Income284,014-2,1328,523-20,75526,58900
Deferred Taxes & Provisions0000000
Cash flow from operations180,726-41,65772,744-57,543-39,655-28,701109,418
Investing Activities
capital expenditure-6,69000-518-408-7,3260
Change in Investments0000000
cash flow from investments-6,69000-518-408-7,3260
Financing Activities
Bank loans0000000
Group/Directors Accounts-161,36534,00058,99168,374000
Other Short Term Loans 0000000
Long term loans0000000
Hire Purchase and Lease Commitments0000000
other long term liabilities0000000
share issue000000100
interest1751,30455499272460274
cash flow from financing-161,19035,30459,54568,473272460374
cash and cash equivalents
cash11,490-6,390132,32510,412-39,792-35,567109,792
overdraft59-36360000
change in cash11,431-6,354132,28910,412-39,792-35,567109,792

berkeley pharma ltd Credit Report and Business Information

Very Low Risk70 - 100
Low Risk50 - 70
Moderate Risk30 - 50
High Risk20 - 30
Very High Risk0 - 20
Get a comprehensive credit check for berkeley pharma ltd. Get real-time insights into berkeley pharma ltd's credit score, group structure and payment trends.

From as little as £6.99

This will not impact your credit rating!

View Credit Report Sample

Berkeley Pharma Ltd Competitor Analysis

BETA
competitor_analysis_table_img

Perform a competitor analysis for berkeley pharma ltd by selecting its closest rivals and benchmarking them against 12 key performance metrics.

berkeley pharma ltd Ownership

BERKELEY PHARMA LTD group structure

Berkeley Pharma Ltd has no subsidiary companies.

Ultimate parent company

BERKELEY PHARMA LTD

08537849

BERKELEY PHARMA LTD Shareholders

prashant ashwin kumar patel 50%
milan ashwin kumar patel 50%

berkeley pharma ltd directors

Berkeley Pharma Ltd currently has 2 directors. The longest serving directors include Mr Milan Patel (May 2013) and Mr Prashant Patel (May 2013).

officercountryagestartendrole
Mr Milan PatelEngland49 years May 2013- Director
Mr Prashant PatelUnited Kingdom47 years May 2013- Director

P&L

March 2020

turnover

4m

+80%

operating profit

-345.6k

0%

gross margin

35.2%

+2.82%

turnover

Turnover, or revenue, is the amount of sales generated by a company within the financial year.

Balance Sheet

March 2020

net assets

-245.7k

-3.47%

total assets

902.9k

+0.46%

cash

182.3k

+0.07%

net assets

Total assets minus all liabilities

berkeley pharma ltd company details

company number

08537849

Type

Private limited with Share Capital

industry

86900 - Other human health activities

incorporation date

May 2013

age

11

accounts

Total Exemption Full

ultimate parent company

None

previous names

N/A

incorporated

UK

address

2nd floor grove house, 55 lowlands road, harrow, HA1 3AW

last accounts submitted

March 2020

berkeley pharma ltd Charges & Mortgages

A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.

We did not find charges/mortgages relating to berkeley pharma ltd.

charges

berkeley pharma ltd Companies House Filings - See Documents

datedescriptionview/download